English

Eligibility Colorectal Cancer NCT00905047

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced or metastatic colo-rectal cancer
Description

Colorectal Carcinoma Advanced Local | Colorectal cancer metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0009402
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205276
UMLS CUI [2]
C0948380
age > or = 18 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
ps-who < or = 2
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
polynuclear neutrophil leukocytes > or = 1500/mm3, platelets > or = 100000/mm3
Description

Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
total bilirubin < or = 3 uln, asat-alat < or = 2.5 uln
Description

Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
effective contraception
Description

Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0700589
written informed consent signed
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
concomitant radiotherapy
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449
contraindication to fluoropyrimidines
Description

Medical contraindication fluoropyrimidine

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0596581
treatment with sorivudine and its chemical analogs such as brivudine
Description

Sorivudine | Sorivudine Analogs | brivudine

Data type

boolean

Alias
UMLS CUI [1]
C0207628
UMLS CUI [2,1]
C0207628
UMLS CUI [2,2]
C0243071
UMLS CUI [3]
C0163272
severe hepatic insufficiency
Description

Hepatic Insufficiency Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C1306571
UMLS CUI [1,2]
C0205082
severe renal insufficiency
Description

Renal Insufficiency Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
pregnant or lactating woman
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
hypersensitivity to capecitabine, 5fu, tegafur or one of its excipients
Description

Hypersensitivity capecitabine | Fluorouracil allergy | Hypersensitivity Tegafur | Hypersensitivity Tegafur Excipient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0671970
UMLS CUI [2]
C0570698
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0016778
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0016778
UMLS CUI [4,3]
C0015237
Back to the top of the page

Similar models

Eligibility Colorectal Cancer NCT00905047

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal Carcinoma Advanced Local | Colorectal cancer metastatic
Item
locally advanced or metastatic colo-rectal cancer
boolean
C0009402 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0948380 (UMLS CUI [2])
Age
Item
age > or = 18 years old
boolean
C0001779 (UMLS CUI [1])
WHO performance status scale
Item
ps-who < or = 2
boolean
C1298650 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement
Item
polynuclear neutrophil leukocytes > or = 1500/mm3, platelets > or = 100000/mm3
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
total bilirubin < or = 3 uln, asat-alat < or = 2.5 uln
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Contraceptive methods
Item
effective contraception
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
written informed consent signed
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure
Item
concomitant radiotherapy
boolean
C1522449 (UMLS CUI [1])
Medical contraindication fluoropyrimidine
Item
contraindication to fluoropyrimidines
boolean
C1301624 (UMLS CUI [1,1])
C0596581 (UMLS CUI [1,2])
Sorivudine | Sorivudine Analogs | brivudine
Item
treatment with sorivudine and its chemical analogs such as brivudine
boolean
C0207628 (UMLS CUI [1])
C0207628 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
C0163272 (UMLS CUI [3])
Hepatic Insufficiency Severe
Item
severe hepatic insufficiency
boolean
C1306571 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Renal Insufficiency Severe
Item
severe renal insufficiency
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating woman
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity capecitabine | Fluorouracil allergy | Hypersensitivity Tegafur | Hypersensitivity Tegafur Excipient
Item
hypersensitivity to capecitabine, 5fu, tegafur or one of its excipients
boolean
C0020517 (UMLS CUI [1,1])
C0671970 (UMLS CUI [1,2])
C0570698 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0016778 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0016778 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
Back to the top of the page